Nutlin-3a and Ferroptosis: A p53 Assay Framework
2026-08-18
Nutlin-3a is a potent MDM2 inhibitor for dissecting p53 pathway activation, cell-cycle control, and apoptosis. This article develops a distinct assay framework that connects MDM2–p53 experiments with the ferroptosis and migration biology described in glioblastoma research.
Pexmetinib (ARRY-614) for Cytokine Assays
2026-08-18
Pexmetinib (ARRY-614) gives researchers a practical way to examine inflammatory cytokine inhibition alongside Tie2-linked signaling. This workflow uses concentration bracketing, whole-blood validation, phospho-protein controls, and dephosphorylation assays to distinguish direct pathway modulation from nonspecific toxicity.
Direct Mouse Genotyping Kit Plus for SCA3 Models
2026-08-17
Discover how the Direct Mouse Genotyping Kit Plus can strengthen genotype-to-phenotype workflows in SCA3/MJD mouse research. This article connects direct tissue lysate PCR with experimental design, model authentication, and interpretation of neuroinflammation and autophagy findings.
Glabridin–Gold(I) Complex Reprograms Tumor Immunity
2026-08-17
The 2025 Advanced Science study develops glabridin–gold(I) complex 6d as an immunomodulatory agent designed to inhibit TrxR and MAPK signaling simultaneously. In liver cancer models, 6d increased dendritic-cell maturation, reduced several immunosuppressive immune populations, lowered tumor-cell PD-L1, and enhanced T-cell granzyme B production, providing a mechanistic rationale for combination immunotherapy studies.
Cryptosporidium AdhE: Imidazole Inhibition and Efficacy
2026-08-16
The reference study establishes the bacterial-type bifunctional aldehyde/alcohol dehydrogenase CpAdhE as a chemically tractable target in Cryptosporidium parvum. Screening and follow-up experiments connect lower-micromolar enzyme inhibition by selected antifungal imidazoles with suppression of parasite growth in vitro, while also defining important limits for target validation and therapeutic translation.
RIPostC, Ketone Bodies, and Ferroptosis in Stroke
2026-08-15
This ACS Chemical Neuroscience study identifies ketone body metabolism as a mechanistic link between remote ischemic postconditioning and neuroprotection after ischemic stroke. Rat and neuronal-cell experiments connect the intervention with improved energy status, reduced iron-dependent lipid peroxidation, preservation of GPX4, and suppression of ACSL4, while also defining important limits for translating ketone-body findings into metabolite-specific studies.
Norovirus Co-opts NINJ1 for Selective Secretion
2026-08-14
Song and colleagues show that murine norovirus uses NINJ1-mediated plasma membrane rupture as part of an unconventional, selective route for releasing the viral protein NS1. The study connects caspase-3 cleavage, NINJ1 recruitment to viral replication sites, and NS1–NINJ1 interaction, while demonstrating that this pathway contributes to oral infection in mice.
iPSC Trial Selection for Ultrarare Disease
2026-08-14
The reference study developed a patient-specific iPSC platform to prescreen therapies for an ultrarare ECHS1-related Leigh-like syndrome before further clinical-trial decisions. Its key contribution is a multisystem, control-based workflow that connected cellular drug responses with a subsequent three-year patient treatment experience, while also clarifying the limits of extrapolating results across genetically distinct disorders.
CPI-613 Workflows for Cancer Metabolism Studies
2026-08-13
Build reproducible tumor cell metabolism studies around CPI-613 with dose–time pilots, orthogonal mitochondrial readouts, and combination-testing strategies. The workflow also translates recent cholangiocarcinoma findings into practical assays for PDHA1 activity, α-ketoglutarate accumulation, apoptosis, and macrophage antigen presentation.
Ceruletide: Designing Better Pancreatic Fibrosis Assays
2026-08-13
Ceruletide, also known as Caerulein, is more than a secretagogue: it is a controllable physiological input for connecting pancreatic injury models with fibrosis biology. This guide explains how to use its receptor-driven effects, product specifications, and mechanistic study design to improve pancreatic function research and assay interpretation.
Sumatriptan Metabolism: CYP and MAO Revisited
2026-08-12
The reference study challenges the prevailing view that sumatriptan is metabolized mainly through MAO A-mediated oxidative deamination. Using recombinant human enzymes and HPLC–MS, it identifies CYP1A2, CYP2C19, and CYP2D6 as contributors to sequential N-demethylation, while confirming selective MAO A activity toward the parent drug and its desmethyl metabolites.
Syringin Enhances Sunitinib in Renal Cell Carcinoma
2026-08-12
A 2024 study identifies syringin as a potential adjunct to sunitinib in renal cell carcinoma (RCC), combining network pharmacology, molecular docking, cell-based assays, and Western blot analysis to connect phenotype with EGFR/PI3K/Akt signaling. The findings suggest a rationale for studying natural-product combinations in sunitinib-resistant RCC, while the available evidence remains preclinical and requires validation in more physiologically representative models.
Sodium Nitroprusside in Sex-Informed Hypertension
2026-08-11
A translational framework for using Sodium Nitroprusside as a nitric oxide donor to separate vascular smooth muscle responsiveness from sex-dependent hemodynamic and autonomic mechanisms in angiotensin II hypertension models.
Flumequine: DNA Topoisomerase II Assay Guide
2026-08-11
Flumequine provides a mechanistically focused way to study DNA topoisomerase II inhibition alongside cell-growth arrest and cell killing. This workflow guide shows how to connect enzyme assays, DNA replication research, and time-resolved cancer drug-response measurements while avoiding common interpretation errors.
Cefodizime for AMR Research Workflows
2026-08-10
Build reproducible susceptibility, resistance-surveillance, and host-response assays around Cefodizime, a third-generation cephalosporin antibiotic. This workflow connects PBP-directed killing with the urban-rodent Escherichia coli findings from Hanoi while emphasizing controls, resistance boundaries, and practical troubleshooting.
560 records 8/38 page Previous Next First page 上5页 678910 下5页 Last page